Intrinsic Value of S&P & Nasdaq Contact Us

United Therapeutics Corporation UTHR

NASDAQ Global Select

SharesGrow Score
80/100
5/7 Pass
SharesGrow Intrinsic Value
$1,320.25
+128.2%
Analyst Price Target
$579.83
+0.2%

United Therapeutics Corporation (UTHR) current share price is $578.54. The gold spot price is $4,808.10 per troy ounce. Using the formula: UTHR in gold = $578.54 × 31.1035 ÷ $4,808.10 = 3.7426 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of UTHR when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding UTHR shares over the measured period.

UTHR in US Dollars
Gold in US Dollars
UTHR in Gold (grams per share)

Real Wealth Growth Rate

UTHR
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{UTHR}_{\text{gold}}(t) = \frac{P_{\text{UTHR}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{UTHR}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{UTHR}_{\text{gold}}^{(T)}}{\text{UTHR}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{UTHR}_\text{gold}^{(0)}$ = initial gold-price, $\text{UTHR}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ALNY
ALNY
Alnylam Pharmaceuticals, Inc.
$339.41
+1.92%
BGNE
BGNE
BeiGene, Ltd.
$184.71
+0.49%
INCY
INCY
Incyte Corporation
$97.69
+2.24%
ASND
ASND
Ascendis Pharma A/S
$249.84
+0.52%
PCVX
PCVX
Vaxcyte, Inc.
$62.76
+1.64%
BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
NUVL
NUVL
Nuvalent, Inc.
$105.02
+1.28%
APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
+0.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message